Acquisition by Sunzen Biotech Berhad ("Sunzen") of the remaining 30% equity interest in Ecolite Biotech Manufacturing Sdn Bhd ("Ecolite"), a 70%-owned subsidiary of Sunzen for a purchase consideration of RM15.00 million; and the acquisition by Sunzen of the remaining 30% equity interest in Yanming Resources Sdn Bhd, a 70%-owned subsidiary of Ecolite, for a purchase consideration of RM4.50 million, to be wholly satisfied by the issuance and allotment of a total of 66,101,694 new ordinary shares in Sunzen ("Sunzen Share(s)") at an issue price of RM0.295 per Sunzen Share
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....